AURKA and adrenal cortex carcinoma: We also created ROC curves for the effect of AURKA alone on survival time in ACC patients, with AUCs of 0.906 (2-year OS), 0.920 (3-year OS), and 0.818 (5-year OS) (Figure 3C).